Numerous countries decided to simply discontinue the manufacturing, distribution and selling of Zantac and its generic equivalents off the market. Here in the United States, the Food and Drug Administration decided to continue testing and determining how nitrosodimethylamine, popularly known as NDMA, forms in the medication. In the meantime, consumers here in Ohio and elsewhere may be wondering whether they will suffer harm from ranitidine.
Many Ohio residents take dietary supplements for a variety of reasons. Part of the problem with the supplements is that they do not undergo testing necessarily undergo the same scrutiny by the Food and Drug Administration as prescribed medications do, which means they are often classified as unapproved drugs, especially if they contain medications ordinarily prescribed by doctors. The recent recall of a dietary supplement claiming to help with libido occurred because it contained an unapproved drug.
If you are like many other heartburn sufferers here in Ohio, you probably take an over the counter medication for relief. If your medication of choice happens to be Zantac, whose generic version is called Ranitidine, the Food and Drug Administration says you could end up with cancer. According to the FDA, this heartburn medication contains approximately 26,000 times the acceptable level of N-nitrosodimethylamine.
When a recall is announced, people here in Ohio and elsewhere need to understand how dangerous the product in question is. The Food and Drug Administration developed a system to identify the severity of the problem. The most dangerous classification the FDA has is a Class I recall, which means the potential for fatalities is high.
As anyone in Ohio with high blood pressure has discovered in recent months, many of the prescription medications out there could cause substantial harm to those who take them. While the Food and Drug Administration can force a recall, the companies who make the medications issue most of the recalls voluntarily. What the FDA does is provide information to the public.
Like others throughout the country, some Ohio residents suffer from migraines. They may get so bad that patients need medication in order to control them. However, like any other drug, it remains vulnerable to contamination that could lead to serious illnesses. The Food and Drug Administration recently announced one migraine medication might contain potentially dangerous micro-bacteria.
Allergan Plc manufactures Biocell tissue expanders and breast implants. After reviewing the evidence, the Food and Drug Administration determined these products could cause significant harm to those who use them here in Ohio or elsewhere. Recently, the agency requested that the company recall these products here in the United States.
Walgreen's stores are everywhere. In addition to having a pharmacy, they sell numerous name brand and in-store brand over-the-counter medications that people here in Ohio and elsewhere purchase. The store brand often retails at a lower price, so many people purchase it in order to save some money, but these products could become the subject of a voluntary or Food and Drug Administration forced recall at any time just as name brand products sometimes are.
Numerous patients here in Ohio and across the country are affected by recent recalls of blood pressure medications. So many drugs are recalled by the Food and Drug Administration that it is feared supplies of those not affected could run out before new, supposedly safer batches of the affected drugs are manufactured. Just when it looked like things were beginning to turn around, the FDA received a report of yet another carcinogen in these prescription medications.
More than likely, Ohio residents diagnosed with high blood pressure are more than aware of all of the recalls for their prescribed medications. The recalls have caused a great deal of trepidation for patients and doctors as they try to deal with the shortage of drugs that do not contain the defects that caused the recalls. Now, the Food and Drug Administration is under scrutiny regarding its policies and procedures when it comes to foreign-made drugs.